On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Current Pharmaceutical Design

JournalCitation impact & published research

Current Pharmaceutical Design is a journal indexed in ScholarIQ from OpenAlex.

What is the OpenAlex record for Current Pharmaceutical Design?

ScholarIQopenalex

The OpenAlex for Current Pharmaceutical Design is on the source record.

What are the most-cited papers on Current Pharmaceutical Design?

ScholarIQmost cited works
Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy
Sho‐ichi Yamagishi, Takahiro Imaizumi
Current Pharmaceutical Design. 2005453 Citations
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Alexios S. Antonopoulos, Marios Margaritis, Regent Lee, Keith M. Channon, Charalambos Antoniades
Current Pharmaceutical Design. 2012432 CitationsOPEN ACCESS
Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Deliang Guo, Erica H. Bell, Paul S. Mischel, Arnab Chakravarti
Current Pharmaceutical Design. 2014322 CitationsOPEN ACCESS
Acute and Long-Term Effects of Cannabis Use: A Review
Laurent Karila, Perrine Roux, Benjamin Rolland, Amine Benyamina, Michel Reynaud, Henri‐Jean Aubin, Christophe Lançon
Current Pharmaceutical Design. 2014308 Citations
Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature
Paolo Giorgini, Paolo Di Giosia, Davide Grassi, Melvyn Rubenfire, Robert D. Brook, Claudio Ferri
Current Pharmaceutical Design. 2015281 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial